top of page
In Country Services
Pre-IND Program Evaluation and Development

Synergy is focused on providing foreign pharmaceutical companies with the services they need to successfully enter the U.S. market.  In effect, Synergy serves as "in-country caretaker" for its foreign customers.  Synergy Research can assist with regulatory affairs, clinical research including  pre-clinical through regulatory approval, and creating a market presence in the United States. This concept has helped many startup firms secure funding to further the R&D effort.

"By using Synergy Research as their local operations, Synergy Research's clients will be able to create their own stable presence in the U.S. market with minimal investment" explains Mario Guralnik, Chief Executive Officer, Synergy Research. "We can help them meet the challenges of moving from a 'virtual' to a 'brick and mortar' company with a presence in the United States." 

Synergy Research's New Jersey facility provides an ideal location to the pharmaceutical industry and Wall Street.  It also allows access to its employees' broad range of skills, industry contacts, and experience in developing pharmaceutical and device products for foreign firms.


Synergy currently represents over 15 foreign device firms as their US Agent.  We also provide Medical Device Reporting Services under the latest guidlines and regulations, taking this huge burden over for virtual / foreign device manufactureres [21 CFR Part 803; MDR regulation section 519(a) of the FFD&C Act, amended by the Safe Medical Devices Act (SMDA) of 1990].

bottom of page